Is Neurocrine Biosciences, Inc. technically bullish or bearish?

As of 3 October 2025, the technical trend for Neurocrine Biosciences, Inc. has changed from bullish to mildly bullish. The weekly and monthly MACD indicators are bullish, while the daily moving averages also indicate a bullish stance. However, the KST shows a mildly bearish signal on both weekly and monthly time frames, and the Dow Theory reflects a mildly bearish view on the weekly basis but is bullish monthly. The Bollinger Bands are mildly bullish in both weekly and monthly contexts. Overall, the strength of the bullish stance is tempered by the mixed signals from KST and Dow Theory.
In terms of performance, Neurocrine has underperformed the S&P 500 over the past week and month, with returns of -3.50% and 0.68% compared to 1.09% and 4.15% for the index, respectively. However, it has outperformed the S&P 500 over the past year with a return of 22.48% versus 17.82%.